Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy

被引:3
作者
Kawahara, Shinnosuke [1 ]
Aoyama, Toru [2 ]
Murakawa, Masaaki [1 ]
Kanemoto, Rei [1 ]
Takahashi, Daishi [1 ]
Kamioka, Yuto [1 ]
Hashimoto, Itaru [2 ]
Maezawa, Yukio [2 ]
Kobayashi, Satoshi [3 ]
Ueno, Makoto [3 ]
Yamamoto, Naoto [1 ]
Oshima, Takashi [1 ]
Yukawa, Norio [2 ]
Rino, Yasushi [2 ]
Saito, Aya [2 ]
Morinaga, Soichiro [1 ]
机构
[1] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, 2-3-2 Nakao,Asahi Ku, Yokohama 2415815, Japan
[2] Yokohama City Univ, Dept Surg, Yokohama, Japan
[3] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Japan
关键词
Pancreatic cancer; survival; prognostic nutritional index; adjuvant treatment; INFLAMMATION ASSESSMENT TOOLS; EPIDEMIOLOGY;
D O I
10.21873/anticanres.16970
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The prognostic nutritional index (PNI) is used as a marker to evaluate the nutritional and immunological status of patients with various cancers. This study aimed to investigate whether preoperative PNI is a prognostic factor in patients with pancreatic cancer who underwent perioperative adjuvant chemotherapy and surgical resection. Patients and Methods: We retrospectively enrolled 232 pancreatic cancer patients who underwent surgical resection with perioperative adjuvant chemotherapy between January 2013 and December 2022. Overall survival (OS) and relapse -free survival (RFS) rates were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazards regression models. Results: The optimal cutoff value for the preoperative PNI was 44.3 in the present study. PNI <44.3 was associated with older age (p<0.001) and affected the clinical course of postoperative adjuvant chemotherapy. The PNI <44.3 had an important influence on the decreased OS (25.1 vs. 39.0 months) and RFS (13.1 vs. 22.8 months). In univariate and multivariate analyses, the preoperative PNI was an independent prognostic factor for OS [hazard ratio (HR)=1.682, 95% confidence interval (CI)=1.059 - 2.673, p=0.028] and RFS (HR=1.559, 95% CI=1.037 - 2.344, p=0.033). Conclusion: Preoperative PNI
引用
收藏
页码:1711 / 1718
页数:8
相关论文
共 22 条
[11]   Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients [J].
Li, Qi ;
Chen, Chen ;
Zhang, Jian ;
Wu, Hong ;
Qiu, Yinghe ;
Song, Tianqiang ;
Mao, Xianhai ;
He, Yu ;
Cheng, Zhangjun ;
Zhai, Wenlong ;
Li, Jingdong ;
Zhang, Dong ;
Geng, Zhimin ;
Tang, Zhaohui .
FRONTIERS IN ONCOLOGY, 2021, 11
[12]   How Do Cytotoxic Lymphocytes Kill Cancer Cells? [J].
Martinez-Lostao, Luis ;
Anel, Alberto ;
Pardo, Julian .
CLINICAL CANCER RESEARCH, 2015, 21 (22) :5047-5056
[13]   An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer [J].
McMillan, Donald C. .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2008, 67 (03) :257-262
[14]  
Michaud D S, 2004, Minerva Chir, V59, P99
[15]   Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JS']JSAP05) [J].
Motoi, Fuyuhiko ;
Kosuge, Tomoo ;
Ueno, Hideki ;
Yamaue, Hiroki ;
Satoi, Sohei ;
Sho, Masayuki ;
Honda, Goro ;
Matsumoto, Ippei ;
Wada, Keita ;
Furuse, Junji ;
Matsuyama, Yutaka ;
Unno, Michiaki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (02) :190-194
[16]   Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors [J].
Rawla, Prashanth ;
Sunkara, Tagore ;
Gaduputi, Vinaya .
WORLD JOURNAL OF ONCOLOGY, 2019, 10 (01) :10-27
[17]   Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249
[18]   Onodera's prognostic nutritional index is a strong prognostic indicator for patients with hepatocellular carcinoma after initial hepatectomy, especially patients with preserved liver function [J].
Tanemura, Akihiro ;
Mizuno, Shugo ;
Hayasaki, Aoi ;
Gyoten, Kazuyuki ;
Fujii, Takehiro ;
Iizawa, Yusuke ;
Kato, Hiroyuki ;
Murata, Yasuhiro ;
Kuriyama, Naohisa ;
Kishiwada, Masashi ;
Sakurai, Hiroyuki ;
Isaji, Shuji .
BMC SURGERY, 2020, 20 (01)
[19]   Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) [J].
Uesaka, Katsuhiko ;
Boku, Narikazu ;
Fukutomi, Akira ;
Okamura, Yukiyasu ;
Konishi, Masaru ;
Matsumoto, Ippei ;
Kaneoka, Yuji ;
Shimizu, Yasuhiro ;
Nakamori, Shoji ;
Sakamoto, Hirohiko ;
Morinaga, Soichiro ;
Kainuma, Osamu ;
Imai, Koji ;
Sata, Naohiro ;
Hishinuma, Shoichi ;
Ojima, Hitoshi ;
Yamaguchi, Ryuzo ;
Hirano, Satoshi ;
Sudo, Takeshi ;
Ohashi, Yasuo .
LANCET, 2016, 388 (10041) :248-257
[20]   Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis [J].
Wang, Zhongtao ;
Wang, Yongjun ;
Zhang, Xinmei ;
Zhang, Tingting .
CLINICA CHIMICA ACTA, 2018, 486 :303-310